Company-wide revenue
Reported revenue in 2021 ¥248.37B Reported revenue in 2025 ¥303.67B
- growth amount
- +¥55.3B
- growth annualized
- +5.2%
- growth total
- +22.3%
Japanese company profile · 3055
TSUMUGU Holdings, Inc.
In its FY2025 public filing, TSUMUGU Holdings, Inc. reports Pharmaceutical Wholesale Business, Medical equipment wholesale, Pharmacy business, Long-Term Care Services, and 1 other reported businesses. The page shows business-level revenue and profit where the source disclosures support comparison.
Original Japanese company name: 株式会社ほくやく・竹山ホールディングス
English company name recorded in Japan's EDINET filer data. English company name source
Reported company-wide figures
What does this company do?
What does this company do?
TSUMUGU Holdings, Inc.'s largest reported business by revenue in FY2025 was Pharmaceutical Wholesale Business.
The business with the highest reported segment profit in FY2025 was Pharmaceutical Wholesale Business.
FY2025 · fiscal year ended March 2026 View original filing ↗ The source document may be in Japanese.
Business structure
How does it make money?
| Business | Sales | Revenue share | Operating profit |
|---|---|---|---|
| Pharmaceutical Wholesale Business | ¥223.24B ↗ | 73.5% | ¥1.2B ↗ |
| Medical equipment wholesale | ¥70.14B ↗ | 23.1% | ¥899M ↗ |
| Pharmacy business | ¥12.65B ↗ | 4.2% | −¥103M ↗ |
| Long-Term Care Services | ¥4.74B ↗ | 1.6% | ¥268M ↗ |
| ICT Business | ¥2.67B ↗ | 0.9% | ¥201M ↗ |
All values are in Japanese yen (JPY). No currency conversion is applied. FY2025 · fiscal year ended March 2026. Revenue and profit are shown only where the filing and data support a comparison.
Original Japanese label
- Pharmaceutical Wholesale Business
- 医薬品卸売事業
- Medical equipment wholesale
- 医療機器卸売事業
- Pharmacy business
- 薬局事業
- Long-Term Care Services
- 介護事業
- ICT Business
- ＩＣＴ事業
- Sales
- 売上高
- Operating profit
- 営業利益
Original Japanese label
- Pharmaceutical Wholesale Business
- 医薬品卸売事業
- Medical equipment wholesale
- 医療機器卸売事業
- Pharmacy business
- 薬局事業
- Long-Term Care Services
- 介護事業
- ICT Business
- ＩＣＴ事業
- Sales
- 売上高
- Operating profit
- 営業利益
Reported Sales by business over time
Reported Sales by business over time
| Fiscal year | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Pharmaceutical Wholesale Business | ¥177.25B | ¥186.62B | ¥199.5B | ¥209.7B | ¥223.24B |
| Medical equipment wholesale | ¥62.26B | ¥66.4B | ¥66.54B | ¥70.03B | ¥70.14B |
| Pharmacy business | ¥13.7B | ¥13.48B | ¥13.29B | ¥12.78B | ¥12.65B |
| Long-Term Care Services | ¥3.82B | ¥4.05B | ¥4.29B | ¥4.39B | ¥4.74B |
| ICT Business | ¥1.48B | ¥1.58B | ¥1.6B | ¥2.38B | ¥2.67B |
All amounts are in Japanese yen (JPY). Each figure links to the original Japanese filing. Blank cells indicate no comparable figure was disclosed. Business figures may not add up to consolidated figures.
What is growing?
What is growing?
Business revenue growth
Pharmaceutical Wholesale Business
Reported revenue in 2021 ¥177.25B Reported revenue in 2025 ¥223.24B
- growth amount
- +¥46B
- growth annualized
- +5.9%
- growth total
- +26.0%
View original filing
ICT Business
Reported revenue in 2021 ¥1.48B Reported revenue in 2025 ¥2.67B
- growth amount
- +¥1.19B
- growth annualized
- +15.8%
- growth total
- +80.1%
View original filing
Medical equipment wholesale
Reported revenue in 2021 ¥62.26B Reported revenue in 2025 ¥70.14B
- growth amount
- +¥7.88B
- growth annualized
- +3.0%
- growth total
- +12.7%
View original filing
ICT Business
Reported profit margin in 2022 +3.7%
Reported profit margin in 2025 +7.5%
- growth margin points
- +3.8
View original filing
Pharmaceutical Wholesale Business
Reported profit margin in 2022 +0.5%
Reported profit margin in 2025 +0.5%
- growth margin points
- +0.0
View original filing
This describes a reported period; it is not a forecast.
What has changed?
What has changed?
Not disclosed or not safely comparable in the available filings.
Source
Public filing
FY2025 · fiscal year ended March 2026
The source document may be in Japanese.
Filing ID: S100YJPG
View original filing ↗Ask about this company
Ask about this company
The source document may be in Japanese.